Related Experiment Video
Updated: Jun 17, 2026
09:25
An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Lung transplantation: is it still an experimental procedure?
Massimo Boffini1, Vito M Ranieri, Mauro Rinaldi
1Department of Cardiac Surgery, San Giovanni Battista Hospital, University of Turin, Turin, Italy.
Current Opinion in Critical Care
|December 19, 2009
Summary
Lung transplantation (LTx) faces challenges with low procedure numbers and suboptimal outcomes. Strategies to increase donor grafts show promise, but primary graft dysfunction and obliterative bronchiolitis remain significant hurdles impacting long-term results.
Area of Science:
- Thoracic Surgery
- Transplantation Immunology
- Pulmonary Medicine
Background:
- Lung transplantation (LTx) is limited by low procedure volume and poorer outcomes compared to other solid organ transplants.
- Addressing these limitations is crucial for advancing LTx as a viable treatment option.
Purpose of the Study:
- To review the causes for the low number of lung transplants performed worldwide.
- To analyze strategies for improving early and late outcomes in lung transplantation.
Main Methods:
- Review of current literature on lung donor pool expansion and graft optimization.
- Analysis of strategies to mitigate primary graft dysfunction and obliterative bronchiolitis.
- Evaluation of ex-vivo lung reconditioning techniques.
Main Results:
- Utilizing marginal and non-heart-beating donors, alongside optimized donor management and ex-vivo reconditioning, can expand the donor pool.
- Primary graft dysfunction and obliterative bronchiolitis remain major challenges affecting LTx outcomes.
- Current strategies for managing these complications yield controversial results.
Conclusions:
- Lung transplantation still exhibits characteristics of an experimental procedure due to limited numbers and variable outcomes.
- While strategies to increase graft availability are effective, they lack universal adoption.
- Improved understanding of primary graft dysfunction and obliterative bronchiolitis pathogenesis is essential for developing better therapeutic approaches.
